Bo Yi
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of SPTLC1 on type 2 diabetes mellitus.
Journal: World journal of diabetes
Published: March 26, 2024
Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline.
Journal: European journal of pharmacology
Published: March 12, 2024
Pathophysiology roles for adenosine 2A receptor in obesity and related diseases.
Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity
Published: February 07, 2022
PERK-Dependent Activation of the JAK2/STAT3 Pathway Contributes to High Glucose-Induced Extracellular Matrix Deposition in Renal Tubular Epithelial Cells.
Journal: International journal of endocrinology
Published: May 08, 2021
Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 08, 2020
Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history.
Journal: Diabetes research and clinical practice
Published: July 02, 2020
Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Journal: Pharmacological research
Published: October 22, 2019
High levels of glucose induce epithelial-mesenchymal transition in renal proximal tubular cells through PERK-eIF2α pathway.
Journal: Chinese medical journal
Published: March 05, 2019
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression.
Journal: Experimental and therapeutic medicine
Published: November 30, 2013
Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein.
Journal: Molecular biology reports
Published: October 24, 2012
Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression.
Journal: Molecular biology reports
Published: April 03, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026